3 September 2025
At the meeting of 5 August 2025 the RMA:
Determined Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| ascariasis | 65/2025 | 66/2025 |
| hookworm infection | 67/2025 | 68/2025 |
| gallstone disease (cholelithiasis) | 69/2025 | 70/2025 |
| hepatitis D infection | 71/2025 | 72/2025 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined New Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| occipital neuralgia | 73/2025 | 74/2025 |
Determined Amendment Statements of Principles (SOPs) for:
| Condition | SOPs | |
|---|---|---|
| sensorineural hearing loss | 75/2025 | 76/2025 |
The above SOPs take effect from 22 September 2025.
Finalised Declaration for:
| Condition | Declaration | Reasons for Decision |
|---|---|---|
| blast-induced mild traumatic brain injury |
Gazetted 18 August 2025
Completed Investigations
The above determinations and declarations conclude the previously advertised investigations into:
- ascariasis
- hookworm disease
- cholelithiasis
- hepatitis D
- occipital neuralgia
- sensorineural hearing loss (focused - definition)
New Investigations
Decided to advertise the following investigations:
- osteoarthritis
- substance use disorder
- immune thrombocytopaenia
- ulnar neuropathy at the elbow
- malignant neoplasm of the cerebral meninges
- cerebral meningioma
- non-freezing cold injury
- malignant neoplasm of the ovary
- migraine
- frostbite
- hepatitis C
- Zika virus infection
- Guillain-Barre syndrome
- popliteal cyst
- toxic retinopathy
- systemic sclerosis
- malignant neoplasm of the eye
- chilblains
- accidental hypothermia
- personality disorder
The above declaration and investigation notices appear in the Government Notices Gazette of 28 August 2025.